The Chitobiose Transporter, chbC, is Required for Chitin Utilization in \u3cem\u3eBorrelia Burgdorferi\u3c/em\u3e by Rhodes, Ryan G. et al.
University of Rhode Island
DigitalCommons@URI
Cell and Molecular Biology Faculty Publications Cell and Molecular Biology
2010
The Chitobiose Transporter, chbC, is Required for
Chitin Utilization in Borrelia Burgdorferi
Ryan G. Rhodes
University of Rhode Island
Janet A. Atoyan
University of Rhode Island
See next page for additional authors
Creative Commons License
This work is licensed under a Creative Commons Attribution 2.0 License.
Follow this and additional works at: https://digitalcommons.uri.edu/cmb_facpubs
This Article is brought to you for free and open access by the Cell and Molecular Biology at DigitalCommons@URI. It has been accepted for inclusion
in Cell and Molecular Biology Faculty Publications by an authorized administrator of DigitalCommons@URI. For more information, please contact
digitalcommons@etal.uri.edu.
Citation/Publisher Attribution
Rhodes, R. G., Atoyan, J. A., & Nelson, D. R. (2010). The chitobiose transporter, chbC, is required for chitin utilization in Borrelia
burgdorferi. BMC Microbiology, 10:21. doi: 10.1186/1471-2180-10-21
Available at: http://dx.doi.org/10.1186/1471-2180-10-21
Authors
Ryan G. Rhodes, Janet A. Atoyan, and David R. Nelson
This article is available at DigitalCommons@URI: https://digitalcommons.uri.edu/cmb_facpubs/3
Rhodes et al. BMC Microbiology 2010, 10:21
http://www.biomedcentral.com/1471-2180/10/21
Open AccessR E S E A R C H  A R T I C L E
© 2010 Rhodes et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Research articleThe chitobiose transporter, chbC, is required for 
chitin utilization in Borrelia burgdorferi
Ryan G Rhodes1,2, Janet A Atoyan1 and David R Nelson*1
Abstract
Background: The bacterium Borrelia burgdorferi, the causative agent of Lyme disease, is a limited-genome organism 
that must obtain many of its biochemical building blocks, including N-acetylglucosamine (GlcNAc), from its tick or 
vertebrate host. GlcNAc can be imported into the cell as a monomer or dimer (chitobiose), and the annotation for 
several B. burgdorferi genes suggests that this organism may be able to degrade and utilize chitin, a polymer of GlcNAc. 
We investigated the ability of B. burgdorferi to utilize chitin in the absence of free GlcNAc, and we attempted to identify 
genes involved in the process. We also examined the role of RpoS, one of two alternative sigma factors present in B. 
burgdorferi, in the regulation of chitin utilization.
Results: Using fluorescent chitinase substrates, we demonstrated an inherent chitinase activity in rabbit serum, a 
component of the B. burgdorferi growth medium (BSK-II). After inactivating this activity by boiling, we showed that 
wild-type cells can utilize chitotriose, chitohexose or coarse chitin flakes in the presence of boiled serum and in the 
absence of free GlcNAc. Further, we replaced the serum component of BSK-II with a lipid extract and still observed 
growth on chitin substrates without free GlcNAc. In an attempt to knockout B. burgdorferi chitinase activity, we 
generated mutations in two genes (bb0002 and bb0620) predicted to encode enzymes that could potentially cleave 
the β-(1,4)-glycosidic linkages found in chitin. While these mutations had no effect on the ability to utilize chitin, a 
mutation in the gene encoding the chitobiose transporter (bbb04, chbC) did block utilization of chitin substrates by B. 
burgdorferi. Finally, we provide evidence that chitin utilization in an rpoS mutant is delayed compared to wild-type cells, 
indicating that RpoS may be involved in the regulation of chitin degradation by this organism.
Conclusions: The data collected in this study demonstrate that B. burgdorferi can utilize chitin as a source of GlcNAc in 
the absence of free GlcNAc, and suggest that chitin is cleaved into dimers before being imported across the 
cytoplasmic membrane via the chitobiose transporter. In addition, our data suggest that the enzyme(s) involved in 
chitin degradation are at least partially regulated by the alternative sigma factor RpoS.
Background
Lyme disease is the most common vector-borne disease in
the United States, with almost 250,000 cases reported
between 1992 and 2006, and approximately 20,000 new
cases reported each year [1]. The disease is contracted from
a tick (Ixodes species) infected with the spirochete Borrelia
burgdorferi. Ixodes ticks typically feed on small vertebrates
such as the white-footed mouse, but humans are sometimes
an accidental host. If an infected-feeding tick is not
removed before transmission occurs, B. burgdorferi dis-
seminates from the site of inoculation and approximately
70% of the time causes a characteristic bulls-eye rash
around the site of the tick bite known as erythema migrans.
An untreated infection may become systemic and involve
connective, neurologic and, to a lesser extent, cardiovascu-
lar tissues resulting in clinical complications such as arthri-
tis, encephalitis or atrioventricular block [2]. While
antibiotic treatment and tick avoidance are effective in
Lyme disease management and prevention, efforts to under-
stand the molecular mechanisms underlying the pathogen's
life cycle and host colonization strategies remain important
for the development of new prophylactic measures.
B. burgdorferi exists exclusively in an enzootic cycle,
moving between its tick vector and vertebrate host. In order
for the tick to transmit B. burgdorferi, it must first obtain
the organism from an infected host as spirochetes are not
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passed transovarially. Once infected, the tick remains so
throughout its life-cycle and can pass the bacterium to naïve
hosts during subsequent blood meals. Spirochetes exist in
low numbers within the unfed-infected tick and are associ-
ated with the midgut epithelium, an interaction mediated by
outer surface proteins such as OspA and OspB [3-5]. How-
ever, as the infected tick takes in a blood meal the number
of spirochetes begins to increase. By 24 hours after initia-
tion of the blood meal, bacteria begin to migrate from the
tick midgut to the salivary glands where they can be trans-
mitted to a new host [6].
B. burgdorferi is a limited-genome organism and relies
heavily on its host (tick or vertebrate) for many essential
nutrients [7,8]. For example, N-acetylglucosamine
(GlcNAc) is required to generate peptidoglycan for cell
wall synthesis and may be shuttled into the glycolytic path-
way to generate ATP [9]. Spirochetes must obtain GlcNAc
from their surrounding environment, and an abundant
source of bound GlcNAc is encountered within the tick in
the form of chitin. This polymer of alternating GlcNAc res-
idues linked by β-(1,4)-glycosidic bonds functions as a
scaffold material for the tick. It is the major component of
the exoskeleton and an integral part of the peritrophic mem-
brane [10]. The peritrophic membrane forms as the tick
feeds and is composed of chitin, proteins, glycoproteins and
proteoglycans. It encases the blood meal and serves as a
permeability barrier between the food bolus and the midgut
epithelium, enhancing digestion and protecting the midgut
epithelium from attack by toxins and pathogens [11-13].
Previous work has demonstrated that B. burgdorferi can
utilize chitobiose in the absence of free GlcNAc [14-17],
and it has been suggested, but not shown, that this bacte-
rium can also utilize longer GlcNAc oligomers (i.e. chitin)
[9]. The ability to degrade chitin could potentially serve
two purposes for the spirochete within the tick midgut.
First, remodeling of the peritrophic membrane during the
molt may serve as an important source of GlcNAc in the
form of free GlcNAc, chitobiose or longer GlcNAc oligom-
ers [18]. The ability to degrade longer GlcNAc oligomers
into chitobiose or free GlcNAc would allow B. burgdorferi
access to an essential nutrient in the nutrient-poor environ-
ment of the unfed tick midgut. Second, studies in I. ricinus,
the European vector for B. burgdorferi sensu lato strains,
suggest that the peritrophic membrane in nymphal ticks
remains intact for at least 30 days after repletion [19]. Thus,
spirochetes apparently must cross the peritrophic mem-
brane in order to successfully colonize the tick midgut epi-
thelium. Studies in B. burgdorferi demonstrate that OspA
and OspB mediate spirochete association with the tick
midgut epithelium shortly after ingestion [3-5], a process
that would presumably be facilitated by a chitinase activity.
A similar mechanism for vector colonization has been
investigated in other organisms that cause vector-borne dis-
ease. It has been demonstrated in Leishmania [20] and
Plasmodium [21,22] that chitinases and N-acetylglu-
cosaminidases play a role in weakening the peritrophic
membrane, thereby allowing invasion of the midgut epithe-
lium of the sandfly and mosquito, respectively.
Inspection of the B. burgdorferi genome reveals both
enzymes and transporters that may be involved in chitin
degradation. There are two genes predicted to be involved
in the cleavage of β-(1,4) glycosidic bonds, a putative β-N-
acetylhexosaminidase (bb0002) and a putative β-glucosi-
dase (bb0620). In addition, previous reports have character-
ized the chitobiose transport system in B. burgdorferi,
which is encoded on circular plasmid 26 (bbb04, bbb05 and
bbb06) [14,15,17]. It is possible that this transport system
plays a role in the utilization of chitin breakdown products
(i.e. chitobiose), a mechanism that has been investigated in
other chitin-degrading microorganisms [23,24].
As described above, B. burgdorferi cannot generate
GlcNAc de novo and must import this essential sugar from
the surrounding environment. Therefore, during in vitro
propagation the addition of free GlcNAc is necessary for
cells to reach optimal cell densities in a single exponential
phase. In the absence of free GlcNAc, B. burgdorferi exhib-
its a unique biphasic growth pattern. In the first exponential
phase cells utilize the residual GlcNAc and chitobiose pres-
ent in complex medium components and grow to approxi-
mately 2.0 × 106 cells ml-1 [14,17]. Cells then become
starved for GlcNAc and exhibit a death phase in which cell
numbers decrease to 1.0 × 105 cells ml-1. By 120 hours cells
begin to grow in a second exponential phase and reach cell
densities greater than 1.0 × 107 cells ml-1. While the source
of GlcNAc in the second exponential phase remains
unknown, it is possible that sequestered forms of this sugar
such as chitin or glycoproteins present in complex medium
components play a role. The goals of this study were to
determine if B. burgdorferi could utilize chitin as a source
of GlcNAc and to identify genes important in the process.
Results
Chitinase activity in rabbit serum
Previous reports have described a chitinase activity in
mammalian tissues and serum [25-28]. In order to investi-
gate chitin utilization by B. burgdorferi, we first determined
if there was an inherent chitinase activity in the growth
medium (BSK-II) that would interfere with subsequent
growth analyses of B. burgdorferi in the presence of chitin.
To test this, we incubated rabbit serum or BSK-II supple-
mented with 7% rabbit serum with three artificial fluores-
cent substrates used to detect chitinase activity: 4-
methylumbelliferyl N-acetyl-β-D-glucosaminide (4-MUF
GlcNAc), 4-methylumbelliferyl β-D-N,N'-diacetylchitobio-
side (4-MUF GlcNAc2) and 4-methylumbelliferyl β-D-
N,N',N"-triacetylchitotrioside (4-MUF GlcNAc3). Results
demonstrated that rabbit serum has a chitinase activity, as
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both 4-MUF GlcNAc2 and 4-MUF GlcNAc3 were cleaved
in the presence of serum or with BSK-II supplemented with
7% serum (Table 1). Interestingly, rabbit serum did not
cleave the 4-MUF GlcNAc substrate (Table 1), indicating
that it does not contain a β-N-acetylglucosaminidase activ-
ity. Next, we inactivated the chitinase activity in rabbit
serum by boiling so that a chitinase-free medium could be
used to evaluate growth of B. burgdorferi on chitin sub-
strates. Rabbit serum was diluted (2-fold) with sterile water
prior to boiling (see Methods) as undiluted serum solidified
when boiled. Boiling for a total of 10 minutes (5 × 2 min)
completely inactivated chitinase activity in rabbit serum
(Table 1).
Growth of wild-type B. burgdorferi on chitin
Inactivating the chitinase activity in rabbit serum allowed
us to perform growth experiments to determine if B. burg-
dorferi possesses a chitinase activity and can utilize chitin
in the absence of free GlcNAc. Previous reports by our lab-
oratory [17] and others [14,15] demonstrated that B. burg-
dorferi exhibits biphasic growth when cultured in the
absence of free GlcNAc, and that chitobiose can substitute
for free GlcNAc resulting in growth to maximum cell den-
sity in a single exponential phase. We repeated those exper-
iments here using BSK-II lacking GlcNAc and
supplemented with 7% boiled rabbit serum. As shown in
Fig. 1, boiling the serum did not have an adverse effect on
cell growth. In addition, when cells were cultured in the
presence of 50 μM chitotriose, 25 μM chitohexose or 0.4%
coarse chitin flakes, maximum cell densities were reached
in a single exponential phase, similar to growth on 1.5 mM
GlcNAc or 75 μM chitobiose (Fig. 1). These results demon-
strate for the first time that B. burgdorferi can use GlcNAc
oligomers (longer than chitobiose) and chitin in the absence
of free GlcNAc.
We conducted two additional growth experiments in
which either the entire medium was inactivated by boiling
(Fig. 2) or the serum was removed altogether (Fig. 3). First,
BSK-II was prepared without bovine serum albumin (BSA)
and supplemented with 7% rabbit serum (not boiled).
Removing the BSA from the medium allowed us to boil
BSK-II with 7% rabbit serum without the medium solidify-
ing. The medium was boiled (5 × 2 min) to inactivate serum
chitinase activity, and the growth experiment described
Table 1: Chitinase activitya in rabbit serum.
Treatment 4-MUF GlcNAc 4-MUF GlcNAc2 4-MUF GlcNAc3
Averageb(± SE)c Average(± SE) Average (± SE)
Serum
Not Boiled 5.6 (± 3.0) 9,279.7 (± 1,321.6) 17,718.9 (± 6,559.2)
Boiled 5.3 (± 2.2) 12.8 (± 3.6) 16.3 (± 5.2)
BSK + 7% Serum
Not Boiled 9.3 (± 4.7) 2,610.6 (± 895.5) 2,931.1 (± 170.0)
Boiled 11.0 (± 4.9) 14.3 (± 8.2) 28.2 (± 14.5)
a Chitinase activity was measured as relative fluorescence units
b Average activity of 3 replicate experiments.
c SE, standard error of the mean
Figure 1 Chitin utilization in medium supplemented with boiled 
rabbit serum. Wild-type cells (B31-A) were cultured in BSK-II without 
GlcNAc and supplemented with 7% boiled rabbit serum. Late-log 
phase cells were diluted to 1.0 × 105 cells ml-1 and the following sub-
strates were added: 1.5 mM GlcNAc (closed circle), No addition (open 
circle), 75 μM chitobiose (closed triangle), 50 μM chitotriose (open tri-
angle), 25 μM chitohexose (closed square) or 0.4% chitin (open square). 
Cells were enumerated daily by darkfield microscopy. This is a repre-
sentative experiment that was repeated five times.
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above was repeated. Removing the BSA from the medium
did not noticeably change cell growth (compare Fig. 2A
with Fig. 1). In contrast, boiling the medium did slow cell
growth with maximum cell densities decreased by more
than one order of magnitude (Fig. 2B). However, cells still
showed the same growth pattern for chitin utilization as
described above, suggesting that they could use chitotriose
and chitohexose in the absence of free GlcNAc.
In another set of growth experiments, rabbit serum was
replaced with a lipid supplement previously described by
Cluss et al [29] to rule out the possibility of residual chi-
tinase activity in boiled serum that was not detected by the
artificial fluorescent substrates. Cells were subcultured at
least twice in a medium containing the lipid supplement
prior to initiating growth experiments without GlcNAc.
Growth of wild-type cells in serum-free BSK-II lacking
GlcNAc and supplemented with 1.5 mM GlcNAc, 75 μM
chitobiose or 25 μM chitohexose resulted in a single expo-
nential phase and a maximum cell density of approximately
1.0 × 107 cells ml-1 (Fig. 3). While the maximum cell den-
sity was approximately one order of magnitude lower than
in BSK-II containing 7% boiled rabbit serum, the growth
pattern was the same as that observed previously with chitin
substrates (compare Fig. 3 with Fig. 1). Of note, cells cul-
tured without GlcNAc in this serum-free medium only
reached a maximum cell density of 8.0 × 105 cells ml-1 in
the second exponential phase, which is more than one order
of magnitude lower than that observed in medium contain-
ing 7% serum.
Figure 2 Chitin utilization in boiled medium without BSA. BSK-II 
without GlcNAc and BSA was supplemented with 7% rabbit serum. 
Wild-type cells were cultured in unboiled medium (A) or medium that 
was boiled for 10 min (B). Late-log phase cells were diluted to 1.0 × 105 
cells ml-1 and the following substrates were added: 1.5 mM GlcNAc 
(closed circle), No addition (open circle), 75 μM chitobiose (closed tri-
angle), 50 μM chitotriose (open triangle) or 25 μM chitohexose (closed 
square). Cells were enumerated daily by darkfield microscopy. This is a 
representative experiment that was repeated three times.
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Figure 3 Chitin utilization in serum-free medium containing a lip-
id supplement. Serum-free BSK-II was supplemented with a lipid mix-
ture. Wild-type cells in late-log phase were diluted to 1.0 × 105 cells ml-
1 in the absence of free GlcNAc and supplemented with the following 
substrates: 1.5 mM GlcNAc (closed circle), No addition (open circle), 75 
μM chitobiose (closed triangle) or 25 μM chitohexose (closed square). 
Cells were enumerated daily by darkfield microscopy. This is a repre-
sentative experiment that was repeated three times.
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Growth of a β-N-acetylhexosaminidase and β-glucosidase 
double mutant on chitin
bb0002 (putative β-N-acetylhexosaminidase) and bb0620
(putative β-glucosidase) are the only obvious genes anno-
tated in the B. burgdorferi genome that encode enzymes
potentially involved in the degradation of chitin. We gener-
ated mutations in bb0002 and bb0620 to determine if elimi-
nating the function of either or both of these genes would
result in a defect in chitobiose or chitin utilization (see
Methods). Both of the single mutant strains and the double
mutant strain were cultured in BSK-II containing 7% boiled
rabbit serum, lacking GlcNAc and supplemented with 75
μM chitobiose or 25 μM chitohexose. As expected from a
previous report [14], the bb0002 mutant (RR04) showed no
defect in chitobiose utilization, and no defect in the ability
of this mutant to utilize chitohexose was observed (data not
shown). Similar results were also obtained for the bb0620
mutant, RR53 (data not shown). The double mutant (RR60)
also showed no defect in chitobiose or chitohexose utiliza-
tion (Fig. 4), suggesting that either these genes are not
involved in chitin degradation or that a redundant activity is
encoded elsewhere in the genome. We also attempted to
generate mutants in two genes with LysM motifs (bb0262
and bb0761) since LysM domains are involved in binding
to peptidoglycan and chitin, typically through the GlcNAc
moiety [30]. We constructed a bb0761 mutant, but it
showed no defect in utilization of GlcNAc oligomers when
cultured in BSK-II lacking GlcNAc and supplemented with
7% boiled rabbit serum and chitobiose or chitohexose (data
not shown). Several attempts to generate a bb0262 mutant
were unsuccessful suggesting this may be an essential gene
due to a role in cell wall synthesis or remodeling.
Growth of a chbC mutant on chitin
Previous work demonstrated that B. burgdorferi uses a
phosphotransferase system (PTS) to import chitobiose, and
bbb04 (chbC) encodes the transporter for this system
[14,15]. We wanted to determine if chbC is necessary for
chitin utilization in B. burgdorferi, as chitobiose transport
has been shown to be important in the chitin utilization
pathways of other organisms [24,31]. To test this, a chbC
deletion mutant was generated (RR34) and cultured in
BSK-II containing 7% boiled rabbit serum without GlcNAc
and supplemented with either 75 μM chitobiose, 50 μM chi-
totriose or 25 μM chitohexose (Fig. 5A). Under all condi-
tions RR34 failed to grow to optimal cell densities, and
only reached 1.8 - 3.6 × 106 cells ml-1 before blebbing and
entering a death phase. In contrast, wild-type cells with a
functional chbC transporter grew to maximal cell densities
without exhibiting a death phase, when cultured without
free GlcNAc and supplemented with chitotriose or chito-
hexose (compare Fig. 5A with Figs. 1 and 2). In addition,
RR34 did not exhibit a second exponential phase when cul-
tured in the absence of free GlcNAc for 434 hours, whether
or not GlcNAc oligomers were present. These results
strongly suggest that chbC, and by extension chitobiose
transport, is necessary for chitin utilization by B. burgdor-
feri.
To confirm that chbC is necessary for growth on chitin
and second exponential phase growth in the absence of free
GlcNAc, we created a complementation plasmid to restore
wild-type function. The complemented chbC mutant (JR14)
was cultured in BSK-II containing 7% boiled rabbit serum,
lacking free GlcNAc and supplemented with 75 μM chito-
biose, 50 μM chitotriose or 25 μM chitohexose (Fig. 5B).
Comparison of the wild type (Fig. 1), the chbC mutant (Fig.
5A), and the chbC-complemented mutant (Fig. 5B) under
these growth conditions demonstrate that the presence of
the functional chbC gene in the complemented mutant
restored wild-type growth on all three substrates in the
absence of free GlcNAc.
Growth of an rpoS mutant on chitin
Previous work in our laboratory demonstrated that the alter-
native sigma factor RpoS partially regulates chitobiose uti-
lization, by regulating the expression of chbC during
GlcNAc starvation [17]. Since chbC is necessary for chitin
Figure 4 β-N-acetylhexosaminidase (bb0002) and β-glucosidase 
(bb0620) double mutant utilizes chitin. Growth of RR60 (double 
mutant) in the presence of chitobiose or chitohexose. Late-log phase 
cells were diluted to 1.0 × 105 cells ml-1 in BSK-II containing 7% boiled 
serum, lacking GlcNAc and supplemented with the following sub-
strates: 1.5 mM GlcNAc (closed circle), No addition (open circle), 75 μM 
chitobiose (closed triangle) or 25 μM chitohexose (open triangle). Cells 
were enumerated daily by darkfield microscopy. This is a representa-
tive experiment that was repeated twice.
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utilization, we hypothesized that RpoS may also be
involved in the regulation of other genes in this pathway. To
test this, we cultured an rpoS mutant (A74) in BSK-II with-
out free GlcNAc, supplemented with 75 μM chitobiose or
25 μM chitohexose and containing either 7% unboiled (Fig.
6A) or boiled (Fig. 6B) rabbit serum. As in our previous
report [17], culturing the rpoS mutant with chitobiose in the
absence of free GlcNAc resulted in biphasic growth. This
was observed in the presence of both unboiled (Fig. 6A)
and boiled (Fig. 6B) rabbit serum with the second exponen-
tial phase starting at 142 hours in either medium. Compari-
son of chitohexose utilization by the rpoS mutant in
unboiled (Fig. 6A) or boiled (Fig. 6B) serum revealed
biphasic growth under both conditions, but with a delay in
the initiation of the second exponential growth phase only
in a medium supplemented with boiled serum. The delay in
second exponential phase growth ranged from 72 to 120 h
in the three replicate experiments conducted. These data
suggest a role for RpoS in the regulation of chitin utilization
separate from its role in regulating chbC expression.
Discussion
Chitin is one of the most abundant polymers in the environ-
ment [32] and is a major structural component of arthro-
pods, including Ixodid ticks, the vector hosts for B.
burgdorferi. B. burgdorferi must obtain GlcNAc from its
tick and vertebrate hosts and does so by transporting either
free GlcNAc or chitobiose into the cell [14-17]. Recently,
Tilly et al [14,15] reported that B. burgdorferi cells exhibit
biphasic growth in the absence of free GlcNAc in vitro. It
was proposed that the second growth phase observed during
GlcNAc starvation was due to the up regulation of chbC
and the utilization of chito-oligomers present in the yeasto-
late component of BSK-II [14]. While we were able to con-
firm that the induction of chbC expression during GlcNAc
starvation is responsible for chitobiose utilization, our
observations suggested that yeastolate is not the source of
sequestered GlcNAc for second exponential phase growth
[17]. Thus, we set out to determine if B. burgdorferi could
utilize chitin given that it is a major component of the tick
peritrophic membrane [11-13]. Chitin utilization could
prove beneficial to spirochetes in the nutrient-limited envi-
ronment of the unfed-infected tick midgut and aid in the
colonization of the midgut epithelium.
Prior to conducting growth studies in the presence of chi-
tin, we determined if there was an inherent chitinase activ-
ity present in the medium. Previous reports characterized
chitinase activity in goat serum [25], guinea pig blood [26],
human macrophages [27] and a variety of mouse tissues
[28]. While chitinase activity has not been previously
described in rabbit serum, the evolutionary conservation of
this enzymatic activity in rodents and primates [33] sug-
gested that it may also be present in rabbit serum. We dem-
onstrated heat-sensitive chitinase activity in rabbit serum
Figure 5 Growth of a chbC mutant and complemented mutant on 
chitin. (A) Growth of RR34 (chbC mutant) in the presence of chitobiose, 
chitotriose and chitohexose. Late-log phase cells were diluted to 1.0 × 
105 cells ml-1 in BSK-II containing 7% boiled serum, lacking GlcNAc and 
supplemented with the following substrates: 1.5 mM GlcNAc (closed 
circle), No addition (open circle), 75 μM chitobiose (closed triangle), 50 
μM chitotriose (open triangle) or 25 μM chitohexose (closed square). 
Cells were enumerated daily by darkfield microscopy. (B) Growth of 
JR14 (RR34 complemented with BBB04/pCE320) in the presence of chi-
tobiose, chitotriose and chitohexose. Late-log phase cells were diluted 
to 1.0 × 105 cells ml-1 in BSK-II containing 7% boiled serum, lacking Gl-
cNAc and supplemented with the following substrates: 1.5 mM Gl-
cNAc (closed circle), No addition (open circle), 75 μM chitobiose 
(closed triangle), 50 μM chitotriose (open triangle) or 25 μM chitohexo-
se (closed square). Cells were enumerated daily by darkfield microsco-
py. These are representative growth experiments that were repeated 
four times.
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(Table 1). In addition, rabbit serum showed no activity
against 4-MUF GlcNAc, suggesting that it possesses chi-
tinase activity but not a β-N-acetylglucosaminidase activity
in which free GlcNAc is released from the non-reducing
end of chitin. These results support our observation that the
source of sequestered GlcNAc in the second exponential
phase is not due to chito-oligomers present in the yeastolate
component of BSK-II [17]. Any chito-oligomers present in
yeastolate would be degraded to chitobiose by the chitinase
activity present in rabbit serum, and imported into the cells
by the chbC transporter.
To determine whether B. burgdorferi could utilize chitin
and GlcNAc oligomers longer than chitobiose, we either
inactivated the chitinase activity in rabbit serum by boiling
before adding it to BSK-II or we replaced the rabbit serum
with a lipid extract. In both cases, B. burgdorferi cells pro-
vided with chitin or various chitin oligomers as the sole
source of GlcNAc grew in one exponential phase to optimal
cell densities (Figs. 1 and 3). In the absence of these added
sources of GlcNAc, the cells failed to grow to high cell den-
sities. These data strongly suggest that B. burgdorferi has
the genes necessary to degrade and utilize chitin or GlcNAc
oligomers in the absence of free GlcNAc.
Additionally, GlcNAc starvation in the absence of rabbit
serum resulted in biphasic growth, but with a lower maxi-
mum cell density in the second exponential phase (Fig. 3).
This suggests that rabbit serum and one or more other com-
ponents in BSK-II contribute the sequestered GlcNAc nec-
essary for growth in the second exponential phase, possibly
in the form of glycoproteins or glycosaminoglycans. It is
interesting to note that boiling the serum or the entire
medium had an impact on the ability of cells to grow in a
second exponential phase in some experiments (Fig. 2B and
Fig. 4). For example, in boiled medium without BSA, cells
did not exhibit a second exponential phase in the absence of
free GlcNAc (Fig. 2B). In another case, a reduced growth
rate and a reduced cell density in the second exponential
phase was observed for RR60 (the bb0002 and bb0620 dou-
ble mutant) in the absence of free GlcNAc (Fig. 4). How-
ever, results with RR60 do not lead us to conclude that
either of these genes play a significant role in obtaining
sequestered GlcNAc in the second exponential phase,
because the wild-type strain grew to the same final cell den-
sity as RR60 in this experiment (data not shown). Addition-
ally, RR60 was cultured in BSK-II lacking GlcNAc and
supplemented with serum that was not boiled, and cells
grew to > 1.0 × 107 cells ml-1 in the second exponential
phase (data not shown). The lack of a second exponential
phase observed in boiled BSK-II (Fig. 2B) and the slower
second exponential phase accompanied by reduced cell
density observed with RR60 (Fig. 4) was occasionally
observed and seemed to correlate with different batches of
boiled medium or serum. This suggests that prolonged boil-
ing alters components within the serum that B. burgdorferi
normally utilizes for second exponential phase growth.
In addition to growth experiments, we attempted to detect
B. burgdorferi chitinase activity using the artificial fluores-
cent substrates described above (data not shown). We used
both culture supernatants and cell lysates from cultures
Figure 6 RpoS regulates chitobiose and chitin utilization. Growth 
of A74 (rpoS mutant) in BSK-II without GlcNAc and supplemented with 
7% unboiled (A) or boiled serum (B). Late-log phase cells were diluted 
to 1.0 × 105 cells ml-1 and cultures were supplemented with the follow-
ing substrates: 1.5 mM GlcNAc (closed circle), No addition (open circle), 
75 μM chitobiose (closed triangle) or 25 μM chitohexose (open trian-
gle). Cells were enumerated daily by darkfield microscopy. This is a rep-
resentative experiment that was repeated three times.
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starved for GlcNAc and supplemented with 7% boiled rab-
bit serum and various GlcNAc oligomers or chitin. While
cells grew to maximum cell densities as expected, we were
unable to detect cleavage of any of the artificial fluorescent
substrates. These results were surprising in light of the
growth experiments (Figs. 1, 2 and 3) and the known ability
of B. burgdorferi to utilize chitobiose [14-17]. It is possible
that the enzyme activity expressed was below the detection
limit of our assay or that the artificial substrates were not
recognized by these enzymes.
While attempts to knockout chitinase activity in this
study were not successful, we did identify other candidates
by genome analysis. We examined genes annotated by The
Institute for Genomic Research (TIGR; http://cmr.jcvi.org)
as hypothetical or conserved hypothetical using the NCBI
Conserved Domain Database (CDD; http://
www.ncbi.nlm.nih.gov/sites/entrez?db=cdd) to target those
genes with domains that could be involved in chitin degra-
dation or chitin binding. We generated a list of potential tar-
gets that included five genes with a potential hydrolase
domain (bb0068, bb0168, bb0421, bb0504 and bb0511),
three with a potential Lysin Motif (LysM; bb0262, bb0323
and bb0761), one with a potential Goose Egg White
Lysozyme domain (GEWL; bb0259) and one with a cyclo-
dextrin transglycosylase domain (CGTase; bb0600). As
noted above, the bb0761 mutant showed no defect in utili-
zation of GlcNAc oligomers and attempts to generate a
bb0262 mutant were unsuccessful suggesting this is an
essential gene with a role in cell wall synthesis or remodel-
ing.
A recent report on Ralstonia A-471 described a novel
goose egg white-type lysozyme gene with chitinolytic
activity [34]. BLAST analysis of the catalytic domain
against the B. burgdorferi genome shows 36% identity at
the amino acid level (E-value is 7.9e-08) to bb0259, which
has a GEWL domain. We did not attempt to knockout this
gene, but it may be a target to consider in future studies.
Since chitobiose transport is important for chitin utiliza-
tion in other organisms [24,31], we evaluated the role of
chbC during chitin utilization in B. burgdorferi. As
expected from previous studies [14,17], RR34 (chbC
mutant) was unable to grow on chitobiose in the absence of
free GlcNAc (Fig. 5A). Similarly, no growth was observed
when RR34 cells were cultured in the absence of GlcNAc
and supplemented with chitotriose or chitohexose, demon-
strating that chbC is also required for the utilization of
GlcNAc oligomers longer than chitobiose. Complementa-
tion of the chbC mutant by introduction of the wild-type
chbC gene on a shuttle vector (Fig. 5B) restores the wild-
type phenotype. Together, these results demonstrate that
chitobiose transport is necessary for the utilization of chito-
biose and longer GlcNAc oligomers, and suggest that an
unidentified enzyme(s) involved in the degradation of chi-
tin is secreted, either extracellularly or into the periplasm.
In addition, these results show that chitobiose transport is
necessary for utilization of sequestered GlcNAc in the sec-
ond exponential phase, and support our hypothesis that
GlcNAc oligomers are not the source of sequestered
GlcNAc in the second exponential phase.
Previous work conducted in our laboratory suggested that
RpoS, one of two alternative sigma factors present in B.
burgdorferi, regulates chitobiose utilization in the B31-A
background by partially regulating expression of chbC dur-
ing GlcNAc starvation [17]. Here we cultured an rpoS
mutant in BSK-II lacking GlcNAc and supplemented with
chitobiose or chitohexose and 7% unboiled (Fig. 6A) or
boiled (Fig. 6B) rabbit serum. Biphasic growth of the rpoS
mutant in the presence of chitobiose was nearly identical in
unboiled and boiled rabbit serum. This is important because
it further demonstrates that unboiled serum does not pos-
sess a β-N-acetylglucosaminidase activity that cleaves chi-
tobiose to monomeric GlcNAc. In contrast, growth of the
rpoS mutant supplemented with chitohexose was delayed in
boiled serum compared to that in unboiled rabbit serum.
This delay supports the data presented in Table 1 showing
an inherent chitinase activity in unboiled rabbit serum as
rpoS mutant growth on chitohexose in unboiled serum (Fig.
6A) mirrors that on chitobiose, suggesting the chitinase
activity in the rabbit serum degraded the chitohexose to chi-
tobiose. In addition, the delay in chitohexose utilization in
boiled serum strongly suggests that RpoS regulates chitin
utilization not only through the regulation of chbC [17], but
also through the regulation of other gene(s) important for
degradation of chitin. Recently, Caimano et al [35] charac-
terized the RpoS regulon in the 297 c162 background after
temperature-shift in vitro and after maintenance in dialysis
membrane chambers in rats or rabbits. We were unable to
find any of our candidate chitin utilization genes upon
examination of differentially regulated genes identified in
their study. It is possible that starvation for GlcNAc is nec-
essary for the induction of these genes, a condition that was
not tested by Caimano et al.
In this study we provide evidence that B. burgdorferi can
utilize GlcNAc oligomers and chitin in the absence of free
GlcNAc, and we show that chitobiose transport via chbC is
required for utilization of these substrates. A previous
report suggested chbC is not required for maintenance or
transmission of the organism between ticks and mice [15].
However, these studies were conducted in a controlled lab-
oratory environment using pathogen-free ticks and mice. It
is possible chbC plays a role in infection in a natural setting
by providing a competitive advantage to spirochetes in col-
onizing ticks that are often colonized with more than one
microorganism. In addition, chbC is required for obtaining
sequestered GlcNAc during second exponential phase
growth in vitro which most likely comes from glycoproteins
or glycosaminoglycans, so there may also be a role for this
transporter in the mammal. However, it is also possible that
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chitinase activity, rather than chitin utilization, is required
for transmission, as chitinase activity may be important for
penetration of the peritrophic membrane and colonization
of the tick midgut. In this instance, the chbC gene may be
retained, but chitobiose uptake and utilization may be of
secondary importance.
Conclusions
In this study we provide evidence of an inherent chitinase
activity in rabbit serum, a component of the B. burgdorferi
growth medium, BSK-II. We inactivated this activity by
boiling, and showed that cells can utilize GlcNAc oligom-
ers and chitin as a source of GlcNAc in the presence of
boiled serum or a lipid supplement. In addition, we demon-
strated that transport of chitobiose via the chitobiose trans-
porter, chbC, is required for chitin utilization by this
organism. Finally, delayed growth of an rpoS mutant on
chitohexose suggests that this alternative sigma factor is
involved in the regulation of chitin utilization.
Methods
Bacterial strains and culture conditions
Bacterial strains and plasmids described in this work are
listed in Table 2. B. burgdorferi strains were maintained in
modified BSK-II [36] supplemented with 7% rabbit serum
and any necessary antibiotics (see Table 2). BSK-II was
modified by replacing 10× CMRL-1066 with 10× Media
199 (Invitrogen Corp.; Carlsbad, CA). Some experiments
were conducted with boiled rabbit serum to inactivate the
inherent chitinase activity. Serum was diluted 2-fold in ster-
ile deionized water, incubated in a boiling water bath for 2
min and allowed to cool to room temperature. Incubation in
the boiling water bath was repeated for a total of 5 times
and 14% of boiled serum was added to BSK-II (final serum
concentration was 7%). In certain growth experiments
serum was replaced with a lipid supplement stock of 26 μM
cholesterol, 12 μM palmitic acid and 12 μM oleic acid [29].
Lipids were transferred to BSK-II as an ethanolic mixture at
a final concentration of 0.1% (vol/vol). Plasmids were
maintained in E. coli DH5α that was cultured in lysogeny
broth (LB; 1% tryptone, 0.5% yeast extract, 1% NaCl) con-
taining the appropriate antibiotic(s) (see Table 2). Antibiot-
ics were used at the following concentrations for B.
burgdorferi strains: streptomycin, 100 μg ml-1; coumermy-
cin A1, 0.5 μg ml-1; kanamycin, 340 μg ml-1. Antibiotics
were used at the following concentrations for E. coli DH5α:
streptomycin 100 μg ml-1; kanamycin, 50 μg ml-1; ampicil-
lin, 200 μg ml-1.
Generation of a β-N-acetylglucosaminidase (bb0002) and 
β-glucosidase (bb0620) double mutant in B. burgdorferi
To generate a bb0002/bb0620 double mutant of B. burgdor-
feri we first generated single mutations for each gene by
deletion of 63 and 81 bp, respectively, and insertion of an
antibiotic resistance gene (streptomycin or kanamycin) as a
selectable marker. The construct used to generate the
bb0002 mutant with streptomycin resistance was created as
follows: (i) a 1.2 kb fragment of the 3' end of bb0002 and
flanking sequence was amplified from B31-A genomic
DNA using primers with engineered restriction sites,
5'BB0002mutF (KpnI) and 5'BB0002mutR (XbaI) (for a
list of primers used in this study see Table 3); (ii) the ampli-
con was TA cloned into pCR2.1 (Invitrogen, Corp.) to gen-
erate pBB0002.3; (iii) pBB0002.3 and pKFSS1 [37] (a B.
burgdorferi shuttle vector conferring streptomycin resis-
tance; Table 2) were digested with KpnI and XbaI and sepa-
rated by gel electrophoresis; (iv) the 1.2 kb fragment from
pBB0002.3 was gel extracted using the QIAquick PCR
Purification Kit (Qiagen, Inc.; Valencia, CA) according to
the manufacturer's instructions, and cloned into the gel
extracted fragment from pKFSS1 to create pBB0002.4; (v)
the 1.2 kb fragment and flanking streptomycin resistance
cassette from pBB0002.4 was PCR amplified using
TaKaRa ExTaq (Fisher Scientific; Pittsburgh, PA) and the
primers 5'BB0002mutF (KpnI) and pKFSS1 R1; (vi) the
resulting 2.7 kb amplicon was TA cloned into pGEM T-
Easy (Promega, Inc.; Madison, WI) to generate
pBB0002.5A or B (based on orientation of the PCR product
insertion); (vii) a pBB0002.5B clone in which the 3' end of
the streptomycin resistance cassette was adjacent to the
XmaI site in the pGEM T-Easy vector was identified by
restriction digest; (viii) the 5' end of bb0002 and flanking
DNA was amplified using primers 3'BB0002mutF (XmaI)
and 3'BB0002mutR (SacII), and TA cloned into pCR2.1 to
create pBB0002.6; (ix) pBB0002.5B and pBB0002.6 were
digested with XmaI and SacII and separated by gel electro-
phoresis; (x) the 2.0 kb fragment from pBB0002.6 was gel
extracted, and cloned into the gel extracted fragment from
pBB0002.5B to create the final construct, pBB0002.7. In
summary, 63 bp of the bb0002 gene was deleted and the
streptomycin cassette under control of the B. burgdorferi
PflgB promoter (from pKFSS1) was inserted in the opposite
orientation.
The construct used to generate the bb0620 mutant with
kanamycin resistance was created as follows: (i) a 2.7 kb
fragment of the 3' end of bb0620 and flanking sequence was
amplified using primers 5'BB0620mutF3 (KpnI) and
5'BB0620mutR2 (SalI); (ii) the amplicon was TA cloned
into pCR2.1 to generate pBB0620.1; (iii) pBB0620.1 and
pBSV2 [38] (a B. burgdorferi shuttle vector conferring
kanamycin resistance; Table 2) were digested with KpnI
and SalI and separated by gel electrophoresis; (iv) the 2.7
kb fragment from pBB0620.1 was gel extracted and cloned
into the gel extracted fragment from pBSV2 to create
pBB0620.2; (v) the 2.7 kb fragment and flanking kanamy-
cin resistance cassette was PCR amplified using primers
5'BB0620mutF3 and pBSV2 R1; (vi) the resulting 4.3 kb
amplicon was TA cloned into pGEM T-Easy to create
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pBB0620.3A or B (based on orientation of the PCR product
insertion); (vii) a pBB0620.3B clone was identified by
restriction digest in which the 3' end of the kanamycin resis-
tance cassette was adjacent to the SacII restriction site in
the pGEM T-Easy vector; (viii) the 5' end of bb0620 and
flanking DNA was amplified using primers
3'BB0620mutF2 (SacII) and 3'BB0620mutR2 (AatII) and
TA cloned into pCR2.1 to create pBB0620.4; (ix)
pBB0620.3B and pBB0620.4 were digested with SacII and
AatII and separated by gel electrophoresis; (x) the 1.7 kb
fragment from pBB0620.4 was gel extracted and cloned
into the gel extracted fragment from pBB0620.3B to create
the final construct, pBB0620.5. In summary, 81 bp near the
5' end of bb0620 were deleted and the kanamycin cassette
under control of the B. burgdorferi PflgB promoter (from
pBSV2) was inserted in the opposite orientation.
All plasmid constructs described above were confirmed
by restriction digestion and/or sequence analysis. Plasmids
pBB0002.7 and pBB0620.5 were used to generate deletion/
insertion mutations in B31-A. Specifically, plasmids were
concentrated to greater than 1 μg μl-1 and 10 μg of each
plasmid was introduced into separate competent B31-A
preparations by electroporation. Cells from each transfor-
mation reaction were resuspended in 10 ml of BSK-II con-
taining 20 μg ml-1 phosphomycin, 50 μg ml-1 rifampicin and
2.5 μg ml-1 amphotericin B (Antibiotic Mixture for Borrelia
100×; Sigma-Aldrich; St. Louis, MO), and allowed to
recover overnight (18-24 h) prior to plating. Cells were
plated on BSK-II containing either 100 μg ml-1 streptomy-
cin (pBB0002.7) or 340 μg ml-1 kanamycin (pBB0620.5)
according to the protocol of Samuels et al [39]. Antibiotic
resistant colonies appearing 10-14 d after plating were
transferred to liquid BSK-II and cell lysates were screened
Table 2: Strains and plasmids used in this study.
Strain or Plasmid Genotype and Description Reference
Strains
B. burgdorferi
B31-A High passage non-infectious wild type [42]
RR04 StrR; B31-A putative β-N-
acetylhexosaminidase (bb0002) mutant
This study
RR53 KanR; B31-A putative β-glucosidase 
(bb0620) mutant
This study
RR60 StrR KanR; B31-A double mutant for bb0002 
and bb0620
This study
RR34 StrR; B31-A chbC mutant This study
JR14 StrR KanR; RR34 complemented with 
BBB04/pCE320
This study
A74 CoumR; B31-A rpoS mutant [42]
E. coli
DH5α supE44 F- lacU169 (ϕ80lacZ M15) 
hsdR17 relA1 endA1gyrA96 thi-1relA1
[43]
Plasmids
pKFSS1 StrR; B. burgdorferi shuttle vector, cp9 
based
[37]
pBSV2 KanR; B. burgdorferi shuttle vector, cp9 
based
[38]
pCE320 KanR ZeoR; B. burgdorferi shuttle vector, 
cp32 based
[40]
pBB0002.7 StrR; aadA::bb0002 This study
pBB0620.5 KanR; kan::bb0620 This study
pBBB04.5 StrR; aadA::bbb04 This study
BBB04/pCE320 KanR; bbb04 complementation construct This study
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by PCR using primers flanking the antibiotic insertion site.
One clone for each mutation was chosen for growth experi-
ments. The bb0002 mutant was designated RR04, and the
bb0620 mutant was designated RR53. Mutations in RR04
and RR53 were confirmed by PCR amplification of
genomic DNA using primers flanking the antibiotic inser-
tion site [Additional file 1 and Additional file 2], and DNA
sequencing confirmed insertion of the antibiotic resistance
gene.
To generate the bb0002/bb0620 double mutant, compe-
tent RR04 cells were transformed with 10 μg of
pBB0620.5. Cells were resuspended in BSK-II and allowed
to recover overnight prior to plating on BSK-II containing
100 μg ml-1 streptomycin and 340 μg ml-1 kanamycin. PCR
was used to screen the transformants and a clone containing
mutations in both genes was designated RR60. In addition,
PCR was conducted on genomic DNA obtained from this
clone using primers flanking the antibiotic insertion site
[Additional file 1 and Additional file 2], DNA sequencing
of the PCR products confirmed insertion of the antibiotic
resistance genes in bb0002 and bb0620.
Construction of a chbC mutant in B. burgdorferi
The construct used to generate a chbC (bbb04) deletion/
insertion in B31-A was created as follows: (i) a 2.6 kb frag-
ment of the 3' end of chbC and flanking DNA was ampli-
fied using primers 5'BBB04mutF2 (BamHI) and
5'BBB04mutR2 (PstI); (ii) the amplicon was TA cloned
into pCR2.1 to generate pBBB04.1; (iii) pBBB04.1 and
pKFSS1 were digested with BamHI and PstI and separated
by gel electrophoresis; (iv) the 2.6 kb fragment from
pBBB04.1 was gel extracted and cloned into the gel
extracted fragment from pKFSS1 to generate pBBB04.2;
(v) the 2.6 kb fragment and flanking streptomycin resis-
tance cassette in pBBB04.2 were PCR amplified using
primers 5'BBB04mutF2 (BamHI) and pKFSS1 R1; (vi) the
resulting 4.0 kb amplicon was TA cloned into pGEM T-
Easy to generate pBBB04.3A or B (based on orientation of
the PCR product insertion); (vii) a pBBB04.3B was identi-
fied by restriction digest in which the 3' end of the strepto-
mycin resistance cassette was adjacent to the XmaI site in
the pGEM T-Easy vector; (viii) the 5' end of bbb04 and
flanking DNA was amplified using primers 3'BBB04mutF1
(XmaI) and 3'BBB04mutR1 (SacII) and TA cloned into
pCR2.1 to create pBBB04.4; (ix) pBBB04.3B and
pBBB04.4 were digested with XmaI and SacII and sepa-
rated by gel electrophoresis; (x) the 1.8 kb fragment from
pBBB04.4 was gel extracted and cloned into the gel
extracted fragment from pBBB04.3B to create the final
construct, pBBB04.5. In summary, 141 bp near the 5' end of
chbC were deleted and the streptomycin resistance gene
under the control of the B. burgdorferi PflgBpromoter (from
pKFSS1) was inserted in the opposite orientation. All plas-
Table 3: Oligonucleotide primers used in this study
Primer Name Sequence (5'T3')
5'BB0002mutF (KpnI) GCTAGGGTACCACATTGCCT
TTATCGGAATATTGACATC
5'BB0002mutR (XbaI) GCTAGTCTAGAAAGATGCGG
AGCAGACAAAGGGAT
pKFSS1 R1 TGATGAACAGGGTCACGTCG
TC
3' BB0002mutF (XmaI) GCTAGCCCGGGCGATATTAA
GCTCTTGAACATTCTTAAA
3'BB0002mutR (SacII) GCTAGCCGCGGTAGTGCTAT
TAGTGCTTTATCTTTATTG
5'BB0620mutF3 (KpnI) GCTAGGGTACCTACTTTGAAT
TTTGAATATGGAG
5'BB0620mutR2 (SalI) GCTAGGTCGACTACCCAAAT
CAATCAATCAC
pBSV2 R1 TTATTATCGTGCACTCCTCCC
GGT
3'BB0620mutF2 (SacII) GCTAGCCGCGGCGTATCCCA
AAAATCAATAGAAAA
3'BB0620mutR2 (AatII) GCTAGGACGTCATGCAATCA
CCGCAATAGAAGCGG
5'BBB04mutF2 (BamHI) GCTAGGGATCCGAATAAGTA
GCTTTACGTCT
5'BBB04mutR2 (PstI) GCTAGCTGCAGTACCAACAG
TGGTATGTTGA
3'BBB04mutF1 (XmaI) GCTAGCCCGGGCCAATTTTG
CTAGCAATAGGA
3'BBB04mutR1 (SacII) GCTAGCCGCGGGCATCTGGA
TTTAGGTCTGCTTTGA
BBB04 complement F1 GCTTCATTACTTCAACAGGAC
GACG
BBB04 complement R1 TCGCTAAGGCGTGTCTCAGC
AATA
chbC F1 GGGAATTCAGCCCAATTCAT
GGTTTCC
chbC R1 GGCGGAACAGACTCTGGAA
GCTTAAT
BB0002 CF1 ATGGACTTTTTAAAAACCTTT
TCTTTTTTGTTTTTTAGC
BB0002 CR1 CTAAGGAATGAGTACTATATT
GACACCCGA
BB0620 mut confirm F1 TCAAGAGTGGTATTGCCGTG
TCCT
BB0620 mut confirm R1 ACTTGAACCCACGACAACTC
GGAT
BBB04 mut confirm F1 AGCAGCATCTCCACCGTAAG
GTAT
BBB04 mut confirm R1 CACCAGAGTAAGCTACAACA
GGCA
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mid constructs were confirmed by restriction digestion and
DNA sequencing.
The chbC deletion/insertion mutation was generated by
transforming B31-A with 10 μg of pBBB04.5 and plating
on BSK-II containing 100 μg ml-1 streptomycin as
described above. Transformants were selected with strepto-
mycin and screened by PCR using primers flanking the
antibiotic insertion site. A single clone, RR34, was chosen
for subsequent growth experiments and the mutation was
confirmed by PCR with primers flanking the antibiotic
insertion site [Additional file 3]. DNA sequencing was per-
formed on the PCR product confirming the insertion of the
streptomycin resistance gene.
Complementation of the chbC mutant
To complement the chbC mutant (RR34) the wild-type
chbC gene (bbb04) and flanking DNA was amplified from
B31-A genomic DNA using primers BBB04 complement
F1 and BBB04 complement R1. The resulting 3.0 kb frag-
ment was TA cloned into pCR2.1 to generate pchbC-
comp.1. Next, pchbCcomp.1 and pBSV2 [38] were
digested with SacI and XbaI and separated by gel electro-
phoresis. The 3.0 kb fragment from pchbCcomp.1 was gel
extracted and cloned into the gel extracted fragment from
pBSV2 to create the complementation construct pchbC-
comp.2. Several attempts were made to complement RR34
with pchbCcomp.2; however, no clones were obtained.
Therefore, we transferred the bbb04 fragment from pchbC-
comp.2 to pCE320 [40], a B. burgdorferi shuttle vector with
a circular plasmid 32 (cp32) origin of replication, by digest-
ing with NotI. The new construct, designated BBB04/
pCE320, was transformed into RR34 and plated on BSK-II
containing 100 μg ml-1 streptomycin and 340 μg ml-1 kana-
mycin as described above. One clone, designated JR14, was
selected for further experiments, and PCR confirmation
showed this clone carried both mutant and wild-type copies
of chbC [Additional file 3].
Nucleotide sequencing and computer analysis
Nucleic acid sequencing was performed by the University
of Rhode Island Genomics and Sequencing Center using a
3130xl Genetic Analyzer (Applied Biosystems; Forest City,
CA). Sequencing reactions were prepared using the Big-
Dye® Terminator v3.0 Cycle Sequencing Kit. Sequences
were analyzed using the DNASTAR Lasergene software
(DNASTAR, Inc.; Madison, WI).
Chitinase activity assay
Chitinase activity assays were performed as previously
described [41] using the following substrates: 4-MUF
GlcNAc, 4-MUF GlcNAc2 and 4-MUF GlcNAc3 (Sigma-
Aldrich). Briefly, 200 μl reactions were prepared by com-
bining 150 μl Tris buffered saline (TBS; 25 mM Tris, 150
mM NaCl), 30 μl of sample and 20 μl of the appropriate
substrate (1 mM stock solution in DMSO) in a black 96
well microtiter plate with a clear bottom (Fisher Scientific).
Plates were incubated at 33°C for up to 48 h, and fluores-
cence was monitored using the SpectraMax2 fluorimeter
(Molecular Devices Corp.; Sunnyvale, CA) with excitation
at 390 nm and emission at 485 nm.
Growth curves
For growth experiments, late-log phase cells (5.0 × 107 to
1.0 × 108 cells ml-1) cultured in complete BSK-II were
diluted to 1.0 × 105 cells ml-1 in 6 ml of BSK-II lacking
GlcNAc. Typically, 6-12 μl of culture was transferred to 6
ml of fresh medium; therefore, negligible amounts of nutri-
ents were transferred with the inoculum. Cultures were sup-
plemented with 1.5 mM GlcNAc, 75 μM chitobiose, 50 μM
chitotriose, 25 μM chitohexose (V-Labs; Covington, LA) or
0.04% (w/v) chitin flakes from crab shells (Sigma-Aldrich).
Chitin oligomers were > 95% pure as determined by the
manufacturer. For experiments in which BSK-II was sup-
plemented with boiled serum or lipid extract, cells were
subcultured (i.e. diluted 1:1000) in fresh medium contain-
ing the appropriate supplement at least two times prior to
the initiation of growth experiments. Therefore, the initial
inoculum from BSK-II containing serum that was not
boiled was diluted 109- fold in BSK-II supplemented with
boiled serum or lipid extract before the initiation of growth
experiments. All growth experiments were carried out at
33°C and 3% CO2. To enumerate cells, 2.5 μl of culture was
transferred to a Petroff-Hauser counting chamber (Hauser
Scientific; Horsham, PA) and cells were counted in all 25
squares by darkfield microscopy. For cultures with a cell
density greater than 1.0 × 107 cells ml-1 a 10-fold dilution in
BSK-II was made prior to loading in the counting chamber.
Each growth curve is representative of multiple indepen-
dent trials, as data could not be pooled due to the length of
experiments and the different times at which bacteria were
enumerated.
Additional material
Abbreviations
GlcNAc: N-acetylglucosamine; BSK-II: Barbour-Stoenner-Kelly medium; 4-MUF
GlcNAc: 4-methylumbelliferyl N-acetyl-β-D-glucosaminide; 4-MUF GlcNAc2: 4-
methylumbelliferyl β-D-N,N'-diacetylchitobioside; 4-MUF GlcNAc3: 4-methy-
lumbelliferyl β-D-N,N',N"-triacetylchitotrioside; BSA: bovine serum albumin;
PTS: phosphotransferase system; LB: lysogeny broth; CoumR: coumermycin A1
Additional file 1 PCR Confirmation of putative β-N-acetylhexosamini-
dase (bb0002) mutants. PCR confirmation of the bb0002 deletion/inser-
tion mutation in RR04 (bb0002 mutant) and RR60 (bb0002 and bb0620 
double mutant).
Additional file 2 PCR Confirmation of β-glucosidase mutations. PCR 
confirmation of the bb0620 deletion/insertion mutation in RR53 (bb0620 
mutant) and RR60 (bb0002 and bb0620 double mutant).
Additional file 3 PCR confirmation of chbC (bbb04) mutation and 
complementation. PCR confirmation of RR34 (bbb04 deletion/insertion 
mutant) and JR14 (RR34 complemented with pBBB04/pCE320).
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resistant; KanR: kanamycin resistant; EryR: erythromycin resistant; StrR: strepto-
mycin resistant.
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